#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Hepatocellular carcinoma Dementia Alzheimer's type Asthma Dermatitis atopic Breast cancer metastatic Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Deafness neurosensory Immunodeficiency Adenovirus infection Osteopetrosis Idiopathic pulmonary fibrosis Myelodysplastic syndrome/myeloproliferative neoplasm overlap syndrome Plasma cell myeloma recurrent Chronic graft versus host disease in intestine Adenocarcinoma pancreas Cardiac arrest Ocular lymphoma Renal cancer metastatic Oesophageal squamous cell carcinoma stage II Epilepsy with myoclonic-atonic seizures Cerebral haemorrhage More trials…

    Learn about Rare Diseases

    Erdheim-Chester disease – Basic Information Methylmalonic acidaemia – Treatment Adrenogenital syndrome – Treatment Arterial tortuosity syndrome – Basic Information Proteus syndrome – Treatment Krabbe’s disease – Basic Information Nodal marginal zone B-cell lymphoma – Treatment Primary biliary cholangitis – Diagnostics Angiosarcoma recurrent – Diagnostics Bronchiolitis obliterans syndrome – Diagnostics More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Technetium (99Mtc) Arginine Hydrochloride AZD0022 RNMB2 Enlicitide Chloride Iobitridol Farletuzumab Ecteribulin Suxamethonium Chloride Clioquinol Triamcinolone Protamine Sulfate Desvenlafaxine Benzoate Lysine Hydrochloride Eftilagimod Alfa Lorazepam Rtx001 TUB-030 Pervi-Neo Tryptophan Artemisia Vulgaris More therapies…

    Learn about Your Condition

    Primary biliary cholangitis Hyperkalaemia Deafness traumatic Peripheral artery thrombosis Dry eye Cervix carcinoma Body mass index increased Head injury Papillary thyroid cancer Renal impairment Progressive multiple sclerosis Stevens-Johnson syndrome Sepsis Lysosomal storage disorder Arterial disorder More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Biliary neoplasm

  • Study of MP0317 with durvalumab, gemcitabine and cisplatin combination therapy as first-line treatment for patients with advanced biliary tract cancer

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Biliary neoplasm
    Investigated Drugs:
    • Cisplatin
    • Durvalumab
    • Gemcitabine
    France

  • Study on Ifinatamab Deruxtecan for Patients with Recurrent or Metastatic Solid Tumors

    Recruiting

    1 1 1
    Investigated Diseases:
    • Biliary neoplasm
    • Adenocarcinoma gastric
    • Malignant melanoma
    Investigated Drugs:
    • Ifinatamab Deruxtecan
    Belgium France Germany Ireland Italy The Netherlands +3

  • Study on AZD0901 and Drug Combination for Patients with Advanced Gastric, Gastroesophageal, and Pancreatic Cancers Expressing Claudin 18.2

    Recruiting

    1 1 1 1
    Investigated Diseases:
    • Biliary neoplasm
    • Adenocarcinoma pancreas
    • Gastric cancer
    Investigated Drugs:
    • Irinotecan Hydrochloride Trihydrate
    • Azd0901
    • Fluorouracil
    Poland Spain

  • Study on the Safety and Effectiveness of MK-2870 Alone or with Other Drugs for Patients with Colorectal, Pancreatic, and Biliary Tract Cancers

    Recruiting

    1 1 1 1
    Investigated Diseases:
    • Biliary neoplasm
    • Ductal adenocarcinoma of pancreas
    • Colorectal cancer
    Investigated Drugs:
    • Buclizine Hydrochloride
    • Codeine Phosphate
    • H2-Receptor Antagonists
    Italy Spain

  • Study on Maintenance Therapy with Cisplatin, Durvalumab, and Trastuzumab for Patients with Advanced Biliary Cancer

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Biliary neoplasm
    Investigated Drugs:
    • Futibatinib
    • Neratinib
    • Binimetinib
    Belgium France

  • Study on Cisplatin, Gemcitabine, and Paclitaxel Albumin-Bound for Patients with Resectable Biliary Tract Cancer at High Risk of Recurrence

    Recruiting

    4 1 1 1
    Investigated Diseases:
    • Biliary neoplasm
    Investigated Drugs:
    • Capecitabine
    • Cisplatin
    • Gemcitabine Hydrochloride
    Italy
1 2
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!